Lawrence Flechner
Impact in
- Aging top 5%
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- FOXO transcription factor regulation
- Ubiquitin and proteasome pathways
Papers in ⓘ
-
- Renal Transplantation Outcomes and Treatments 2
- Urology 2
- Urological Disorders and Treatments 2
- Co-authors
- Marc Montminy (5 shared papers)Robert A. Screaton (1 shared paper)Ling Qi (1 shared paper)Fayçal Boussouar (1 shared paper)Xinmin Zhang (1 shared paper)Wu Xu (1 shared paper)Hiroshi Takemori (1 shared paper)Susan Hedrick (1 shared paper)
- Journals
- The Journal of Urology (3 papers)Molecular and Cellular Biology (3 papers)Molecular Cell (2 papers)PLoS ONE (2 papers)Asian Journal of Andrology (1 paper)
- Partner nations
- United StatesJapanIndia
In The Last Decade
Lawrence Flechner
18 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Aging 44
- Molecular Biology 1.2k
- Transplantation 47
- Endocrinology, Diabetes and Metabolism 242
- Geriatrics and Gerontology 52
Countries citing papers authored by Lawrence Flechner
This map shows the geographic impact of Lawrence Flechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Flechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Flechner more than expected).
Fields of papers citing papers by Lawrence Flechner
This network shows the impact of papers produced by Lawrence Flechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Flechner. The network helps show where Lawrence Flechner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Flechner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism Hit paper breakdown → | 2005 | 815 |
| 2 | 2003 | 215 | |
| 3 | 2004 | 177 | |
| 4 | 1999 | 99 | |
| 5 | 1998 | 70 | |
| 6 | 2011 | 69 | |
| 7 | 2015 | 66 | |
| 8 | 2006 | 61 | |
| 9 | 1999 | 46 | |
| 10 | 2010 | 46 | |
| 11 | 2012 | 32 | |
| 12 | 2012 | 26 | |
| 13 | Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth. | 2000 | 24 |
| 14 | 2011 | 18 | |
| 15 | 2003 | 11 | |
| 16 | 2018 | 8 | |
| 17 | 2006 | 6 | |
| 18 | 2012 | 2 | |
| 19 | 2014 | 0 |
About Lawrence Flechner
Lawrence Flechner is a scholar working on Transplantation, Urology, Physiology, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Genomics and Chromatin Dynamics (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Urological Disorders and Treatments (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer-related gene regulation (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Aging (44 citations), Molecular Biology (1.2k citations), Transplantation (47 citations), Endocrinology, Diabetes and Metabolism (242 citations) and Geriatrics and Gerontology (52 citations). Lawrence Flechner has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Marc Montminy, Robert A. Screaton, Ling Qi, Fayçal Boussouar, Xinmin Zhang, Wu Xu, Hiroshi Takemori, Susan Hedrick, Shawn Jeffries and Seung‐Hoi Koo. Their work appears in journals such as The Journal of Urology, Molecular and Cellular Biology, Molecular Cell, PLoS ONE and Asian Journal of Andrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.